NFG
VNDA icon

Nations Financial Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Nations Financial Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.7K Hold
14,000
– – ﹤0.01% 780
2026
Q1 		$96.7K Hold
14,000
– – 0.01% 762
2025
Q4 		$123K Sell
14,000
-500
-3% -$2.75K 0.01% 735
2025
Q3 		$72.4K Hold
14,500
– – ﹤0.01% 706
2025
Q2 		$68.4K Hold
14,500
– – ﹤0.01% 675
2025
Q1 		$66.6K Buy
+14,500
New +$67.6K 0.01% 648

Other funds holding VNDA

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Nations Financial Group's VNDA Position: Q2 2026 in Review

Nations Financial Group held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 14,000 shares worth $85.7K. The position accounts for ﹤0.01% of the portfolio, ranked #780.

Nations Financial Group first reported a position in VNDA in Q1 2025 and has held it in 6 quarters since. The position peaked at $123K in Q4 2025. 24 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Nations Financial Group held 14,000 shares of Vanda Pharmaceuticals worth $85.7K as of Q2 2026.
  • Nations Financial Group left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Nations Financial Group's portfolio in Q2 2026, its #780 holding.
  • Nations Financial Group first reported a position in Vanda Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Nations Financial Group's Vanda Pharmaceuticals position peaked at $123K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.